You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Androgen Antagonists

Showing 1 - 25 of 1,431
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in Atlanta, Charleston (Opaganib, Abiraterone, Enzalutamide)

Recruiting
  • Prostate Cancer
  • Atlanta, Georgia
  • +1 more
Jan 7, 2022

Prostate Cancer, Neoadjuvant Therapy, Androgen Antagonists Trial in Leuven (ARN-509, Degarelix, Placebo)

Recruiting
  • Prostate Cancer
  • +3 more
  • Leuven, Vlaams-brabant, Belgium
    University Hospitals Leuven
Dec 23, 2020

Breast Cancer With or Without BRCA Mutation

Recruiting
  • Breast Cancer
  • Androgen receptor status and BRCA mutation
  • Varanasi, UP, India
    Banaras Hindu University
Jun 2, 2022

Locally Advanced Salivary Gland Carcinoma, Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma Trial

Not yet recruiting
  • Locally Advanced Salivary Gland Carcinoma
  • +3 more
  • Biopsy
  • +3 more
  • (no location specified)
Jan 10, 2023

Prostate Carcinoma, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in Houston (drug, procedure,

Recruiting
  • Prostate Carcinoma
  • +6 more
  • Abiraterone Acetate
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 10, 2022

Prostatic Tumors Trial in Korea, Republic of (Leuprorelin, Goserelin, Triptorelin)

Recruiting
  • Prostatic Neoplasms
  • Cheongju, Korea, Republic of
  • +9 more
Jul 28, 2021

Metastatic Malignant Tumor in Lymph Node, Prostate Ductal Adenocarcinoma, Stage III Prostate Adenocarcinoma AJCC v7 Trial in

Active, not recruiting
  • Metastatic Malignant Neoplasm in Lymph Node
  • +3 more
  • Antiandrogen Therapy
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 3, 2022

Prostate Adenocarcinoma, Prostate Cancer, Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Trial in Boston (Apalutamide

Not yet recruiting
  • Prostate Adenocarcinoma
  • +2 more
  • Apalutamide [Erleada], darolutamide [Nubeqa], or enzalutamide [Xtandi]
  • Prostate-Specific Membrane Antigen (PSMA) PET/CT Scan
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jan 4, 2023

Prostate Cancer Trial in Worldwide (Degarelix, approved GnRH agonist, Radiotherapy)

Recruiting
  • Prostate Cancer
  • Brussels, Belgium
  • +38 more
Sep 3, 2021

Androgen Deprivation Therapy, Prostate Cancer, Hypertension Trial (Gonadotropin-Releasing Hormone Agonist, Androgen receptor

Not yet recruiting
  • Androgen Deprivation Therapy
  • +4 more
  • Gonadotropin-Releasing Hormone Agonist
  • +2 more
  • (no location specified)
Jan 18, 2023

In-vitro Diagnostic Test to Predict COVID-19 Mortality and

Recruiting
  • SARS-CoV 2
  • +5 more
  • CAG length <22
  • CAG length >=22
  • Madrid, Spain
    Hospital Universitario Ramon y Cajal
Feb 17, 2022

Prostate Cancer, Prostate Adenocarcinoma Trial (drug, other, procedure)

Not yet recruiting
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • (no location specified)
Feb 2, 2023

Prostatic Tumors Trial in Worldwide (Antiandrogen, Antiandrogen+docetaxel)

Active, not recruiting
  • Prostatic Neoplasms
  • Copenhagen, Denmark
  • +4 more
Aug 12, 2021

Non-Muscle Invasive Bladder Cancer Trial in Québec (Bicalutamide, Control Arm)

Recruiting
  • Non-Muscle Invasive Bladder Cancer
  • Québec, Canada
    CHU de Québec-Université Laval
Jul 13, 2022

Prostate Cancer Trial (Darolutamide 300 mg, Placebo of Darolutamide)

Not yet recruiting
  • Prostate Cancer
  • Darolutamide 300 mg
  • Placebo of Darolutamide
  • (no location specified)
Feb 10, 2022

Cancer of Prostate Trial in Belgium (Apalutamide, Leuprorelin Acetate 45Mg Powder for Injection Suspension Vial, Goserelin

Recruiting
  • Cancer of Prostate
  • Aalst, Belgium
  • +8 more
Aug 4, 2021

Prostate Cancer Trial (Radiation Therapy, Apalutamide, Luteinising Hormone Releasing Hormone analog agonist (LHRHa))

Withdrawn
  • Prostate Cancer
  • Radiation Therapy
  • +3 more
  • (no location specified)
Aug 13, 2020

Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 Trial in Philadelphia

Recruiting
  • Prostate Adenocarcinoma
  • +2 more
  • MRI-guided Intensity-Modulated Radiation Therapy
  • +7 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Jan 4, 2023

Salivary Gland Cancer, Metastatic, Advanced Trial in Toronto (Selinexor, EGFR or HER2 Inhibitor, FGFR Inhibitor)

Recruiting
  • Salivary Gland Cancer
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Feb 18, 2022

Stage IV Prostate Adenocarcinoma AJCC v7 Trial in Worldwide (drug, other, procedure)

Recruiting
  • Stage IV Prostate Adenocarcinoma AJCC v7
  • Antiandrogen Therapy
  • +5 more
  • Duarte, California
  • +13 more
Feb 24, 2022

PSA Level Greater Than 0.03, PSA Progression, Stage I Prostate Adenocarcinoma AJCC (American Joint Committee on Cancer ) v7

Active, not recruiting
  • PSA Level Greater Than 0.03
  • +4 more
  • Antiandrogen Therapy
  • +2 more
  • Los Angeles, California
  • +1 more
Oct 14, 2021

Prostate Cancer Trial in Philadelphia (drug, radiation, genetic)

Active, not recruiting
  • Prostate Cancer
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Dec 7, 2020

Prostatic Tumors Trial in Worldwide (Darolutamide (Nubeqa, BAY1841788), Placebo, Androgen deprivation therapy (ADT))

Recruiting
  • Prostatic Neoplasms
  • Darolutamide (Nubeqa, BAY1841788)
  • +2 more
  • Macquarie University, New South Wales, Australia
  • +157 more
Jul 28, 2022

Circulating Tumor Cell, Metastatic Prostate Cancer Trial in Netherlands (Cabazitaxel, Antihistamine, Corticosteroid)

Active, not recruiting
  • Circulating Tumor Cell
  • Metastatic Prostate Cancer
  • Delft, Netherlands
  • +8 more
Aug 19, 2021

Prostate Cancer Trial in United States (Velcade, LH-RH Agonist, Androgen Receptor Antagonists)

Terminated
Has Results
  • Prostate Cancer
  • Loma Linda, California
  • +3 more
Oct 17, 2018